We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll
โฆ LIBER โฆ
Long-term follow-up of patients with superficial transitional cell carcinoma of the urinary bladder treated by intravesical mitomycin C
โ Scribed by Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Natalio Walach; Dr. Yoav Horn
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 436 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Efficacy of intravesical mitomycin C in
โ
Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn
๐
Article
๐
1989
๐
John Wiley and Sons
๐
English
โ 301 KB
๐ 1 views
Transitional cell carcinoma of the urina
โ
Igor Frank; John C. Cheville; Michael L. Blute; Christine M. Lohse; Ajay Nehra;
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 95 KB
๐ 1 views
## Abstract ## BACKGROUND Patients with transitional cell carcinoma (TCC) of the urinary bladder metastatic to regional lymph nodes (LN) typically have a poor prognosis. However, some patients are cured by radical cystectomy alone. The goal of this study was to identify predictors of survival in t